
FDA clears new antibiotic for superbug infections
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
Newsletters and Deep Dive digital magazine
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.
Media reports suggest the Trump administration is preparing a new executive order that would seek thousands of layoffs at federal health agencies.
Newel Health has been granted EU certification for its VR-based digital therapeutic for chronic pain, clearing the way for its launch in Europe.
Leela Barham sets out some wider context to the latest blog from NICE on the cost-effectiveness threshold used by the agency and highlights the opportunity for stakeholders to build their c
Editor's Picks
Newsletters and Deep Dive
digital magazine